The antibacterial effect of cefixime results from inhibition of mucopeptide synthesis in the bacterial cell wall. (Jusuf Zimeri) do dit e jets sate sht nj faqe e biografis sate, andaj kujdesu t shkruash mir, sepse nj faqe e keqe e ndyn gjith librin (Sami Frashri) Shok t mire, libra t mir dhe nj ndrgjegje t prgjumur: kjo sht jeta ideale. As a result, many organisms resistant to penicillins and some cephalosporins due to the presence of beta-lactamases, may be susceptible to cefixime. Lexim is highly stable in the presence of beta-lactamase enzymes. Lexim, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Lexim has marked in -vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organisms including beta lactamase producers.Ĭlinical efficacy of Lexim has been demonstrated in infections caused by commonly occurring pathogens including Gram-positive organism Streptococcus pneumoniae, Streptococcus pyogenes, Gram-negative organism Escherichia coli, Proteus mirabilis, Klebsiella spp., Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative), Salmonella typhi and Enterobacter species. It is a bactericidal antibiotic, kills bacteria by interfering in the synthesis of the bacterial cell wall.
Lexim is a semi-synthetic, broad spectrum cephalosporin antibiotic of third generation for oral administration.
